We are live on
!
Find out more
GCA
Greenwood Capital Associates Portfolio holdings
AUM
$1.02B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+11.02%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$772M
AUM Growth
+$83.7M
(+12%)
Cap. Flow
+$20M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
23.79%
Holding
277
New
30
Increased
91
Reduced
113
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$8.37M |
| 2 |
UnitedHealth
UNH
|
+$6.9M |
| 3 |
Stryker
SYK
|
+$5.97M |
| 4 |
Amazon
AMZN
|
+$5.71M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$6.39M |
| 2 |
NXP Semiconductors
NXPI
|
+$5.81M |
| 3 |
Abbott
ABT
|
+$5.43M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$5.14M |
| 5 |
HOLX
Hologic
HOLX
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 8.29% |
| 4 | Industrials | 8.18% |
| 5 | Communication Services | 5.63% |
Similar funds
SVCP
EFM
CC
MSA
MAM
IAS
WA
GA
Greenwood Capital Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Greenwood Capital Associates held 277 positions worth $772M, up 12% from $688M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Greenwood Capital Associates's Q4 2023 filing shows 30 new, 91 increased, 113 reduced and 31 closed positions. Its largest new stake was UnitedHealth: 12,932 shares worth $6.81M. The largest sale was Thermo Fisher Scientific, an estimated $6.39M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Greenwood Capital Associates's largest Q4 2023 buy was UnitedHealth: 12,932 shares worth $6.81M.
- Greenwood Capital Associates added most to Berkshire Hathaway Class B in Q4 2023, an estimated $8.37M increase.
- Greenwood Capital Associates's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $6.39M.
- Greenwood Capital Associates fully exited NXP Semiconductors in Q4 2023, selling an estimated $5.81M.
- Greenwood Capital Associates's ten largest holdings make up 24% of its $772M portfolio in Q4 2023.
- Greenwood Capital Associates opened 30 new positions and closed 31 in Q4 2023.
- Greenwood Capital Associates's portfolio value rose 12% quarter-over-quarter to $772M.
Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.